Do analysts recommend MCTA or SGRY?

Surgery Partners has a consensus target price of $22.18, indicating a potential upside of 28.74%. Given Surgery Partners' stronger consensus rating and higher probable upside, analysts plainly believe Surgery Partners is more favorable than Charming Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Charming Medical 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Surgery Partners 1 Sell rating(s) 2 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.75

Which has higher valuation and earnings, MCTA or SGRY?

Charming Medical has higher earnings, but lower revenue than Surgery Partners. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Charming Medical N/A N/A N/A N/A N/A Surgery Partners $3.34B 0.67 -$77.90M -$0.60 N/A

Do analysts recommend AGL or MCTA?

Agilon Health currently has a consensus price target of $58.73, indicating a potential downside of 46.75%. Given Agilon Health's stronger consensus rating and higher possible upside, research analysts plainly believe Agilon Health is more favorable than Charming Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Agilon Health 2 Sell rating(s) 8 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.20 Charming Medical 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better valuation & earnings, AGL or MCTA?

Charming Medical has lower revenue, but higher earnings than Agilon Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Agilon Health $5.93B 0.31 -$391.35M -$21.56 N/A Charming Medical N/A N/A N/A N/A N/A

Do analysts prefer MCTA or VRDN?

Viridian Therapeutics has a consensus target price of $38.79, indicating a potential upside of 99.93%. Given Viridian Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe Viridian Therapeutics is more favorable than Charming Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Charming Medical 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Viridian Therapeutics 1 Sell rating(s) 0 Hold rating(s) 13 Buy rating(s) 0 Strong Buy rating(s) 2.86

Which has preferable earnings & valuation, MCTA or VRDN?

Charming Medical has higher earnings, but lower revenue than Viridian Therapeutics. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Charming Medical N/A N/A N/A N/A N/A Viridian Therapeutics $70.85M 28.22 -$342.60M -$3.32 N/A

Do analysts prefer ADUS or MCTA?

Addus HomeCare presently has a consensus price target of $131.00, suggesting a potential upside of 24.56%. Given Addus HomeCare's stronger consensus rating and higher possible upside, research analysts clearly believe Addus HomeCare is more favorable than Charming Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Addus HomeCare 1 Sell rating(s) 2 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 2.70 Charming Medical 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better earnings and valuation, ADUS or MCTA?

Addus HomeCare has higher revenue and earnings than Charming Medical. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Addus HomeCare $1.45B 1.36 $95.91M $5.41 19.44 Charming Medical N/A N/A N/A N/A N/A

Which has better earnings and valuation, SNDA or MCTA?

Charming Medical has lower revenue, but higher earnings than Sonida Senior Living. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Sonida Senior Living $381.14M 5.23 -$70.78M -$5.83 N/A Charming Medical N/A N/A N/A N/A N/A

Charming Medical (MCTA) Competitors

$29.36 -0.01 (-0.02%)

As of 07/1/2026

Compare

MCTA vs. SGRY, AGL, VRDN, ADUS, and SNDA

Should you buy Charming Medical stock or one of its competitors? MarketBeat compares Charming Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Charming Medical include Surgery Partners (SGRY), Agilon Health (AGL), Viridian Therapeutics (VRDN), Addus HomeCare (ADUS), and Sonida Senior Living (SNDA). These companies are all part of the "healthcare" industry.

How does Charming Medical compare to Surgery Partners?

Charming Medical (NASDAQ:MCTA) and Surgery Partners (NASDAQ:SGRY) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and risk.

Charming Medical has higher earnings, but lower revenue than Surgery Partners.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Charming Medical	N/A	N/A	N/A	N/A	N/A
Surgery Partners	$3.34B	0.67	-$77.90M	-$0.60	N/A

Surgery Partners has a consensus target price of $22.18, indicating a potential upside of 28.74%. Given Surgery Partners' stronger consensus rating and higher probable upside, analysts plainly believe Surgery Partners is more favorable than Charming Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Charming Medical	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Surgery Partners	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.75

Charming Medical has a net margin of 0.00% compared to Surgery Partners' net margin of -2.28%. Surgery Partners' return on equity of 1.04% beat Charming Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Charming Medical	N/A	N/A	N/A
Surgery Partners	-2.28%	1.04%	0.41%

In the previous week, Surgery Partners had 1 more articles in the media than Charming Medical. MarketBeat recorded 1 mentions for Surgery Partners and 0 mentions for Charming Medical. Charming Medical's average media sentiment score of 1.93 beat Surgery Partners' score of 1.78 indicating that Charming Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Charming Medical	Very Positive
Surgery Partners	Very Positive

Summary

Surgery Partners beats Charming Medical on 8 of the 10 factors compared between the two stocks.

How does Charming Medical compare to Agilon Health?

Agilon Health (NYSE:AGL) and Charming Medical (NASDAQ:MCTA) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, dividends, earnings, media sentiment, valuation, risk, analyst recommendations and institutional ownership.

Charming Medical has lower revenue, but higher earnings than Agilon Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agilon Health	$5.93B	0.31	-$391.35M	-$21.56	N/A
Charming Medical	N/A	N/A	N/A	N/A	N/A

Charming Medical has a net margin of 0.00% compared to Agilon Health's net margin of -6.09%. Charming Medical's return on equity of 0.00% beat Agilon Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Agilon Health	-6.09%	-146.03%	-24.55%
Charming Medical	N/A	N/A	N/A

Agilon Health currently has a consensus price target of $58.73, indicating a potential downside of 46.75%. Given Agilon Health's stronger consensus rating and higher possible upside, research analysts plainly believe Agilon Health is more favorable than Charming Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agilon Health	2 Sell rating(s)	8 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.20
Charming Medical	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Agilon Health had 1 more articles in the media than Charming Medical. MarketBeat recorded 1 mentions for Agilon Health and 0 mentions for Charming Medical. Charming Medical's average media sentiment score of 1.93 beat Agilon Health's score of 0.67 indicating that Charming Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Agilon Health	Positive
Charming Medical	Very Positive

Summary

Agilon Health beats Charming Medical on 5 of the 9 factors compared between the two stocks.

How does Charming Medical compare to Viridian Therapeutics?

Charming Medical (NASDAQ:MCTA) and Viridian Therapeutics (NASDAQ:VRDN) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, analyst recommendations, profitability, earnings, valuation and media sentiment.

In the previous week, Viridian Therapeutics had 12 more articles in the media than Charming Medical. MarketBeat recorded 12 mentions for Viridian Therapeutics and 0 mentions for Charming Medical. Charming Medical's average media sentiment score of 1.93 beat Viridian Therapeutics' score of 0.95 indicating that Charming Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Charming Medical	Very Positive
Viridian Therapeutics	Positive

Viridian Therapeutics has a consensus target price of $38.79, indicating a potential upside of 99.93%. Given Viridian Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe Viridian Therapeutics is more favorable than Charming Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Charming Medical	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Viridian Therapeutics	1 Sell rating(s)	0 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.86

Charming Medical has higher earnings, but lower revenue than Viridian Therapeutics.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Charming Medical	N/A	N/A	N/A	N/A	N/A
Viridian Therapeutics	$70.85M	28.22	-$342.60M	-$3.32	N/A

Charming Medical has a net margin of 0.00% compared to Viridian Therapeutics' net margin of -490.31%. Charming Medical's return on equity of 0.00% beat Viridian Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Charming Medical	N/A	N/A	N/A
Viridian Therapeutics	-490.31%	-80.19%	-48.84%

Summary

Viridian Therapeutics beats Charming Medical on 5 of the 9 factors compared between the two stocks.

How does Charming Medical compare to Addus HomeCare?

Addus HomeCare (NASDAQ:ADUS) and Charming Medical (NASDAQ:MCTA) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, valuation, earnings, analyst recommendations, profitability, risk and dividends.

Addus HomeCare has a net margin of 6.89% compared to Charming Medical's net margin of 0.00%. Addus HomeCare's return on equity of 9.80% beat Charming Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Addus HomeCare	6.89%	9.80%	7.34%
Charming Medical	N/A	N/A	N/A

95.3% of Addus HomeCare shares are held by institutional investors. 4.1% of Addus HomeCare shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Addus HomeCare presently has a consensus price target of $131.00, suggesting a potential upside of 24.56%. Given Addus HomeCare's stronger consensus rating and higher possible upside, research analysts clearly believe Addus HomeCare is more favorable than Charming Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Addus HomeCare	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.70
Charming Medical	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Addus HomeCare had 2 more articles in the media than Charming Medical. MarketBeat recorded 2 mentions for Addus HomeCare and 0 mentions for Charming Medical. Charming Medical's average media sentiment score of 1.93 beat Addus HomeCare's score of 1.83 indicating that Charming Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Addus HomeCare	Very Positive
Charming Medical	Very Positive

Addus HomeCare has higher revenue and earnings than Charming Medical.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Addus HomeCare	$1.45B	1.36	$95.91M	$5.41	19.44
Charming Medical	N/A	N/A	N/A	N/A	N/A

Summary

Addus HomeCare beats Charming Medical on 11 of the 12 factors compared between the two stocks.

How does Charming Medical compare to Sonida Senior Living?

Sonida Senior Living (NYSE:SNDA) and Charming Medical (NASDAQ:MCTA) are both small-cap services companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, valuation, risk, media sentiment, profitability and institutional ownership.

Charming Medical has a net margin of 0.00% compared to Sonida Senior Living's net margin of -24.15%. Charming Medical's return on equity of 0.00% beat Sonida Senior Living's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sonida Senior Living	-24.15%	-36.98%	-7.08%
Charming Medical	N/A	N/A	N/A

In the previous week, Sonida Senior Living had 2 more articles in the media than Charming Medical. MarketBeat recorded 2 mentions for Sonida Senior Living and 0 mentions for Charming Medical. Charming Medical's average media sentiment score of 1.93 beat Sonida Senior Living's score of 0.33 indicating that Charming Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Sonida Senior Living	Neutral
Charming Medical	Very Positive

Charming Medical has lower revenue, but higher earnings than Sonida Senior Living.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sonida Senior Living	$381.14M	5.23	-$70.78M	-$5.83	N/A
Charming Medical	N/A	N/A	N/A	N/A	N/A

87.6% of Sonida Senior Living shares are owned by institutional investors. 39.3% of Sonida Senior Living shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Sonida Senior Living presently has a consensus target price of $41.25, indicating a potential downside of 2.01%. Given Sonida Senior Living's stronger consensus rating and higher probable upside, equities research analysts plainly believe Sonida Senior Living is more favorable than Charming Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sonida Senior Living	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20
Charming Medical	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Sonida Senior Living beats Charming Medical on 7 of the 11 factors compared between the two stocks.

Get Charming Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MCTA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MCTA vs. The Competition

Export

Metric	Charming Medical	Services – Health Industry	Services Sector	NASDAQ Exchange
Market Cap	$497.27M	$2.07B	$24.85B	$12.41B
Dividend Yield	N/A	N/A	5.42%	6.14%
P/E Ratio	N/A	22.56	13.11	24.94
Price / Sales	N/A	8.10	41.34	93.78
Price / Cash	N/A	2,099.15	361.81	59.26
Price / Book	N/A	30.63	13.44	6.46
Net Income	N/A	-$30.36M	-$12.63M	$336.81M
7 Day Performance	N/A	3.68%	2.99%	2.55%
1 Month Performance	-0.02%	12.22%	-0.13%	0.32%
1 Year Performance	N/A	N/A	0.69%	25.76%

Charming Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MCTA Charming Medical	N/A	$29.36 0.0%	N/A	N/A	$497.27M	N/A	N/A	49	Positive News Analyst Forecast High Trading Volume
SGRY Surgery Partners	3.3633 of 5 stars	$14.53 -0.1%	$22.18 +52.7%	-26.4%	$1.90B	$3.31B	N/A	16,000	Positive News Options Volume
AGL Agilon Health	1.3867 of 5 stars	$111.15 -1.7%	$58.73 -47.2%	+86.4%	$1.89B	$5.82B	N/A	1,076
VRDN Viridian Therapeutics	3.7083 of 5 stars	$17.28 -2.0%	$36.14 +109.2%	+27.7%	$1.82B	$70.92M	N/A	50	Analyst Forecast
ADUS Addus HomeCare	4.2612 of 5 stars	$96.09 +1.1%	$131.00 +36.3%	-9.5%	$1.77B	$1.42B	17.76	50,659	News Coverage Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:MCTA) was last updated on 7/2/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Charming Medical (MCTA) Competitors

MCTA vs. SGRY, AGL, VRDN, ADUS, and SNDA

How does Charming Medical compare to Surgery Partners?

Summary

How does Charming Medical compare to Agilon Health?

Summary

How does Charming Medical compare to Viridian Therapeutics?

Summary

How does Charming Medical compare to Addus HomeCare?

Summary

How does Charming Medical compare to Sonida Senior Living?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MCTA vs. The Competition

Charming Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Charming Medical (MCTA) Competitors

MCTA vs. SGRY, AGL, VRDN, ADUS, and SNDA

How does Charming Medical compare to Surgery Partners?

Which has higher valuation and earnings, MCTA or SGRY?

Do analysts recommend MCTA or SGRY?

Is MCTA or SGRY more profitable?

Does the media refer more to MCTA or SGRY?

Summary

How does Charming Medical compare to Agilon Health?

Which has better valuation & earnings, AGL or MCTA?

Is AGL or MCTA more profitable?

Do analysts recommend AGL or MCTA?

Does the media favor AGL or MCTA?

Summary

How does Charming Medical compare to Viridian Therapeutics?

Does the media prefer MCTA or VRDN?

Do analysts prefer MCTA or VRDN?

Which has preferable earnings & valuation, MCTA or VRDN?

Is MCTA or VRDN more profitable?

Summary

How does Charming Medical compare to Addus HomeCare?

Is ADUS or MCTA more profitable?

Do insiders and institutionals have more ownership in ADUS or MCTA?

Do analysts prefer ADUS or MCTA?

Does the media prefer ADUS or MCTA?

Which has better earnings and valuation, ADUS or MCTA?

Summary

How does Charming Medical compare to Sonida Senior Living?

Is SNDA or MCTA more profitable?

Does the media favor SNDA or MCTA?

Which has better earnings and valuation, SNDA or MCTA?

Do institutionals & insiders believe in SNDA or MCTA?

Do analysts recommend SNDA or MCTA?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MCTA vs. The Competition

Charming Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools